Evaluation of Anticancer and Antimicrobial Potentials of Tarantula cubensis Venom (Theranekron® D6)

Yıl 2024, Cilt: 17 Sayı: 3, 626 - 637, 31.12.2024

Nazan Gökşen Tosun , Özlem Kaplan , Aykut Özgür

https://doi.org/10.18185/erzifbed.1463282

Öz

Tarantula cubensis venom (Theranekron®D6) is widely used in veterinary medicine as a drug with anti-tumor, wound healing, anti-inflammatory, antiphlogistic properties. The purpose of the study was to explore Theranekron®D6 (TD6)'s antibacterial activity and its impact on apoptotic cell death in human colon and liver cancer cell lines. TD6 showed a dose and time dependent cytotoxic effect at 12h and 24h in HT-29 and HUH-7 cancer cell lines. The IC50 values of TD6 were calculated as 12.18 µg/mL and 25.10 µg/mL in HT-29 and HUH-7 cell lines at 24h, respectively. TD6 induced apoptosis in HT-29 and HUH-7 cell lines. In these cells exposed to TD6, while the BAX/BCL-2 ratio and CASP-3 mRNA level increased, the HSP90 mRNA and protein level decreased. Also, TD6 exhibited antimicrobial activities against Pseudomonas aeruginosa, Enterococcus faecalis, Klebsiella pneumonia, Staphylococcus aureus, Candida albicans and Candida utilis. Obtained results demonstrated that TD6 has great potentials as alternative therapeutic for cancer and infectious diseases as apoptosis inducer and antimicrobial agent.

Anahtar Kelimeler

Cancer, Tarantula cubensis, Apoptosis, Antibacterial, Antifungal

Proje Numarası

2019/76

Teşekkür

This research received funding from the Foundation of Scientific Research Projects at Tokat Gaziosmanpaşa University (Project number: 2019/76).

Kaynakça

• [1] Utkin, Y. N., (2015) Animal venom studies: Current benefits and future developments, World J Biol Chem, 6 (2) 28-33.
• [2] Mohamed Abd El-Aziz, T., Garcia Soares, A., and Stockand, J. D., (2019) Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving, Toxins (Basel), 11 (10)
• [3] Chatterjee, B., (2018) Animal Venoms have Potential to Treat Cancer, Curr Top Med Chem, 18 (30) 2555-2566.
• [4] Chen, N., Xu, S., Zhang, Y., and Wang, F., (2018) Animal protein toxins: origins and therapeutic applications, Biophys Rep, 4 (5) 233-242.
• [5] Wu, T. et al., (2019) Spider venom peptides as potential drug candidates due to their anticancer and antinociceptive activities, J Venom Anim Toxins Incl Trop Dis, 25 e146318.
• [6] Khusro, A., Aarti, C., Barbabosa-Pliego, A., Rivas-Caceres, R. R., and Cipriano- Salazar, M., (2018) Venom as therapeutic weapon to combat dreadful diseases of 21(st) century: A systematic review on cancer, TB, and HIV/AIDS, Microb Pathog, 125 96- 107.
• [7] Lotfollahzadeh, S., Alizadeh, M. R., Mohri, M., and Mokhber Dezfouli, M. R., (2012) The therapeutic effect of Tarentula cubensis extract (Theranekron(R)) in foot-and- mouth disease in cattle: a randomised trial in an endemic setting, Homeopathy, 101 (3) 159-64.
• [8] Dolapcioglu, K. et al., (2013) Theranekron for treatment of endometriosis in a rat model compared with medroxyprogesterone acetate and leuprolide acetate, Eur J Obstet Gynecol Reprod Biol, 170 (1) 206-10.
• [9] Gul Satar, N. Y., Cangul, I. T., Topal, A., Kurt, H., Ipek, V., and Onel, G. I., (2017) The effects of Tarantula cubensis venom on open wound healing in rats, J Wound Care, 26 (2) 66-71.
• [10] Kizilay, Z., Aktas, S., Cetin, N. K., Kilic, M. A., and Ozturk, H., (2019) Effect of Tarantula Cubensis Extract (Theranekron) on Peripheral Nerve Healing in an Experimental Sciatic Nerve Injury Model in Rats, Turk Neurosurg, 29 (5) 743-749.
• [11] Adib-Hashemi, F. et al., (2016) Retraction note: Anti-inflammatory and protective investigations on the effects of Theranekron(R) "an alcoholic extract of the Tarantula 635 Evaluation of Anticancer and Antimicrobial Potentials of Tarantula cubensis Venom (Theranekron® D6) cubensis" on wound healing of peritoneal in the rat: an in vivo comparative study, Diagn Pathol, 11 (1) 118.
• [12] Gultiken, N. et al., (2015) Tarantula cubensis extract alters the degree of apoptosis and mitosis in canine mammary adenocarcinomas, J Vet Sci, 16 (2) 213-9. [13] Adib-Hashemi, F. et al., (2015) Anti-inflammatory and protective investigations on the effects of Theranekron(R) "an alcoholic extract of the Tarantula cubensis" on wound healing of peritoneal in the rat: an in vivo comparative study, Diagn Pathol, 10 19.
• [14] Oryan, A., Moshiri, A., and Meimandi Parizi, A., (2012) Alcoholic extract of tarantula cubensis improves sharp ruptured tendon healing after primary repair in rabbits, Am J Orthop (Belle Mead NJ), 41 (12) 554-60.
• [15] Cam, Y., Kibar, M., Atasever, A., Atalay, O., and Beyaz, L., (2007) Efficacy of levamisole and Tarantula cubensis venom for the treatment of bovine cutaneous papillomatosis, Vet Rec, 160 (14) 486-8.
• [16] Richardson-Boedler, C., (2002) The brown spider Loxosceles laeta: source of the remedy Tarentula cubensis?, Homeopathy, 91 (3) 166-70.
• [17] Tosun, N. G., Kaplan, Ö., and Özgür, A., (2021) Apoptosis Induced by Tarantula cubensis Crude Venom (Theranekron® D6) in Cancer Cells, Revista Brasileira de Farmacognosia,
• [18] Erzurumlu, Y., Dogan, H. K., Catakli, D., and Aydogdu, E., (2022) Tarantula cubensis Extract Induces Cell Death in Prostate Cancer by Promoting Autophagic Flux/ER Stress Responses and Decreased Epithelial-Mesenchymal Transition, Revista Brasileira de Farmacognosia, 32 (4) 575-582.
• [19] Kaplan, Ö., (2023) Synergistic induction of apoptosis in liver cancer cells: exploring the combined potential of doxorubicin and XL-888, Medical Oncology, 40 (11) 318.
• [20] Gökşen Tosun, N. and Kaplan, Ö., (2022) Biosynthesis of Silver Nanoparticles Using White Propolis Extract as a Reduction Agent and Optimized by Box-Behnken Design, Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi, 25 (5) 933-945.
• [21] Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., and Wallace, M. B., (2019) Colorectal cancer, Lancet, 394 (10207) 1467-1480.
• [22] Martin, J. et al., (2020) Colorectal liver metastases: Current management and future perspectives, World J Clin Oncol, 11 (10) 761-808.
• [23] Falzone, L., Salomone, S., and Libra, M., (2018) Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium, Front Pharmacol, 9 1300.
• [24] Zainal Abidin, S. A., Lee, Y. Q., Othman, I., and Naidu, R., (2019) Malaysian Cobra Venom: A Potential Source of Anti-Cancer Therapeutic Agents, Toxins (Basel), 11 (2)
• [25] Li, L., Huang, J., and Lin, Y., (2018) Snake Venoms in Cancer Therapy: Past, Present and Future, Toxins (Basel), 10 (9)
• [26] Li, B. et al., (2018) Triggering of cancer cell cycle arrest by a novel scorpion venom- derived peptide-Gonearrestide, J Cell Mol Med, 22 (9) 4460-4473.
• [27] Lian, W., Lian, H., Li, Q., Hu, A., and Liu, S., (2018) The venom of spider Haplopelma hainanum suppresses proliferation and induces apoptosis in hepatic cancer cells by caspase activation in vitro, J Ethnopharmacol, 225 169-177.
• [28] Liu, X., Chen, S., Tu, J., Cai, W., and Xu, Q., (2016) HSP90 inhibits apoptosis and promotes growth by regulating HIF-1alpha abundance in hepatocellular carcinoma, Int J Mol Med, 37 (3) 825-35
• [29] Boroumand, N. et al., (2018) Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives, J Pharm Pharmacol, 70 (2) 151-158.
• [30] Nouri-Vaskeh, M., Alizadeh, L., Hajiasgharzadeh, K., Mokhtarzadeh, A., Halimi, M., and Baradaran, B., (2020) The role of HSP90 molecular chaperones in hepatocellular carcinoma, J Cell Physiol, 235 (12) 9110-9120.
• [31] Zhang, S., Guo, S., Li, Z., Li, D., and Zhan, Q., (2019) High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer, PeerJ, 7 e7946.
• [32] He, K., Zheng, X., Zhang, L., and Yu, J., (2013) HSP90 inhibitors promote p53- dependent apoptosis through PUMA and BAX, Mol Cancer Ther, 12 (11) 2559-68.
• [33] Gallerne, C., Prola, A., and Lemaire, C., (2013) HSP90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by BCL-2, Biochim Biophys Acta, 1833 (6) 1356-66.
• [34] Şumnulu, D. (2024) Cytotoxic Effects of Theranekron D6 on HepG2 Hepatocellular Carcinoma Cells, Cumhuriyet Science Journal, 45(1) 8-14.
• [35] Vanli, S., Kurtoglu, F., Alan, B. S., Akcakavak, G., and Ozdemir, O. (2024) Investigation of the effects of Theranekron and Sorafenib treatments on carcinogenesis, apoptosis and biochemical profile in hepatocellular carcinoma in rats, Toxicology Mechanisms and Methods, 1–11.
• [36] Akcakavak, G., and Ozdemir, O. (2023) Effect of Tarantula cubensis alcoholic extract on tumour pathways in azoxymethane-induced colorectal cancer in rats, Acta Veterinaria Brno, 92(1) 79-88.
• [37] Taspinar, N. (2023) The Synergistic Effect of Theranekron and Cisplatin on the Neuroblastoma (SH-SY5Y) Cell Line, Turkish Neurosurgery, 33(6).
• [38] Campos, L. B., Pucca, M. B., Roncolato, E. C., Netto, J. C., and Barbosa, J. E., (2012) Analysis of phospholipase A2, L-amino acid oxidase, and proteinase enzymatic activities of the Lachesis muta rhombeata venom, J Biochem Mol Toxicol, 26 (8) 308- 14.
• [39] Hiu, J. J. and Yap, M. K. K., (2020) Cytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l-amino acid oxidase, Biochem Soc Trans, 48 (2) 719-731.
• [40] Bocian, A. and Hus, K. K., (2019) Antibacterial properties of snake venom components, Chem. Pap., 74 407-419.